Literature DB >> 22495193

Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.

J Oh1, M J Kemper.   

Abstract

Steroid sensitive (minimal change) nephrotic syndrome (MCNS) has been regarded as immunological disorder because of clinical and experimental evidence as well as the response to immunosuppressive treatment. Recent work increased dramatically the understanding of podocyte biology which may be the key structure involved in MCNS, Interestingly many treatment options which were thought to work via an immunosuppressive pathway are now known to have a direct -non immunological- impact on the glomerular filtration barrier, i.e. the podocyte. Aim of this review is the presentation of recent research regarding the podocyte biology but also concerning the treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495193

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  3 in total

1.  Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome.

Authors:  Franca Iorember; Diego Aviles; Mahmoud Kallash; Oluwatoyin Bamgbola
Journal:  Pediatr Nephrol       Date:  2017-09-01       Impact factor: 3.714

Review 2.  Idiopathic nephrotic syndrome: the EBV hypothesis.

Authors:  Claire Dossier; Agnès Jamin; Georges Deschênes
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

Review 3.  Pathogenesis of minimal change nephrotic syndrome: an immunological concept.

Authors:  Seong Heon Kim; Se Jin Park; Kyoung Hee Han; Andreas Kronbichler; Moin A Saleem; Jun Oh; Beom Jin Lim; Jae Il Shin
Journal:  Korean J Pediatr       Date:  2016-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.